Drug General Information
Drug ID	D0P0DA
Former ID	DIB000475
Drug Name	BM-162115
Drug Type	Small molecular drug
Indication	Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25]		Investigative	[534587]
Company	Boehringer Mannheim GmbH
Structure		Download 2D MOL 3D MOL
Formula	C11H10O4
Canonical SMILES	C12(OC(=O)CC2)OC2(C1)C=CC(=O)C=C2
CAS Number	CAS 115077-66-2
PubChem Compound ID	196711
Target and Pathway
Target(s)	Phospholipase A2	Target Info	Inhibitor	[534587]
BioCyc Pathway	Phospholipases
KEGG Pathway	Glycerophospholipid metabolism
	Ether lipid metabolism
	Arachidonic acid metabolism
	Linoleic acid metabolism
	alpha-Linolenic acid metabolism
	Metabolic pathways
	Ras signaling pathway
	Vascular smooth muscle contraction
	Pancreatic secretion
	Fat digestion and absorption
Pathway Interaction Database	Fc-epsilon receptor I signaling in mast cells
Reactome	Acyl chain remodelling of PC
	Acyl chain remodelling of PE
	Acyl chain remodelling of PI
WikiPathways	Glycerophospholipid biosynthesis
References
Ref 534587	Investigation on the effect of experimental phospholipase A2 inhibitors on the formyl-methionyl-leucyl-phenylalanine-stimulated chemotaxis of human leukocytes in vitro. Arzneimittelforschung. 1998 Jan;48(1):77-81.
Ref 534587	Investigation on the effect of experimental phospholipase A2 inhibitors on the formyl-methionyl-leucyl-phenylalanine-stimulated chemotaxis of human leukocytes in vitro. Arzneimittelforschung. 1998 Jan;48(1):77-81.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.